Purchase Order 12305B21P0231
- Not listed
- This is a $232,150 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian federal agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PROMETHION FLOW CELL PACKS, which are a key consumable component of Oxford Nanopore's PromethION sequencing platform. The contract has a period of performance through May 1, 2028. Oxford Nanopore Technologies Inc. is an established federal...
- This firm-fixed-price purchase order was awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $15,040 contract is for the provision of Oxford Nanopore's proprietary library preparation kits and flow cells for long-read DNA/RNA sequencing to support ongoing NIDCD research projects. This award...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the delivery of RNA sequencing kits, ligation sequencing kits, rapid barcoding kits, and flow cells. The $70,000.00 firm-fixed-price purchase order was awarded by the Southeast Area office of a civilian federal agency. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts to provide...
- This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of nanopore flow-cells and a ligation kit. The $19,227.99 firm fixed-price purchase order was awarded by the Northeast Area division of the U.S. Department of Agriculture's Agricultural Research Service. The contract has an ultimate completion date of May 10, 2024. Oxford Nanopore has secured multiple federal contracts and Indefinite Delivery Vehicles (IDVs)...
- This firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Oxford Nanopore Technologies, Inc., a foreign-owned, for-profit biotechnology company. The $19,965.00 award is for the delivery of Promethion flow cell packs and related sequencing reagents. This contract has an ultimate completion date of December 30, 2025 and does not utilize any set-aside designations. Oxford Nanopore Technologies provides advanced genomic...
- This is a $24,950 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a PROMETHION SEQUENCING INSTRUMENT AND REAGENT STARTER PACKAGE, with a performance period ending on May 21, 2026. Oxford Nanopore Technologies Inc. is the prime contractor and there are no subcontractors mentioned. The contract is not...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was made by the National Institute for Minority Health and Health Disparities, a civilian agency. The $16,500.00 firm fixed-price purchase order is for the delivery of OXFORD NANOPORE TECHNOLOGIES, INC.; FLOW CELL R9 4.1 products by December 31, 2023. This contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the supply of 36 PromethION Flow Cell Packs, which are consumables used in Oxford Nanopore's advanced nanopore-based genomic sequencing equipment. The award has a ceiling value of $90,050.00 and an ultimate completion date of November 30, 2023. This purchase order...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, is for the procurement of 8 packs of 4 PromethION flow cells (RNA) at a ceiling value of $21,835.00. The contract is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health. The contract does not utilize a set-aside designation and has an ultimate completion date of September 26, 2025....
This is a $161,638 firm-fixed-price purchase order awarded by the Northeast Area division of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of ROSEN - Oxford Nanopore FLO-PRO002 Promethion Flow Cell Packs, which are consumable supplies for Oxford Nanopore's PromethION DNA/RNA sequencing platform. The contract has a completion date of September 14, 2022 and does not have a set-aside designation. Oxford Nanopore Technologies Inc. has been awarded multiple federal contracts and IDVs (Indefinite Delivery Vehicles) by agencies such as the NIH, CDC, USDA, DOD, and FDA for the provision of its advanced genomic sequencing technologies and associated products and services. The parent company, Oxford Nanopore Technologies PLC, has also received federal contract awards, including a $167,924 purchase order from the CDC for COVID-19 detection products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($92) | 5/20/25 | |
| Not listed | Not listed | $161.7k | 9/14/21 |